Vertex Pharmaceuticals is working toward making its recently approved non-opioid pain medicine Journavx not only broadly ...

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...

Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

SpotDraft, an AI-driven contract lifecycle management platform, secures USD 54 million in Series B funding led by Vertex Growth Singapore and Trident Partners. The funding will accelerate global ...

SpotDraft’s software includes AI-assisted redlining tools, which is the process of editing a contract where two or more ...

AI-driven enterprise tech startup SpotDraft has raised $54 Mn in its Series B funding round led by Vertex Growth and Trident ...

SpotDraft, the CLM platform that helps in-house legal teams manage their contract ecosystems, has raised $54 million in ...

Vertex Pharmaceuticals fair value estimate is US$706 Vertex... To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this year ...

SpotDraft was founded in 2017 by Carnegie Mellon graduate Madhav Bhagat and Harvard Law School alumnus Shashank Bijapur with ...

SpotDraft, a contract lifecycle management platform with AI-powered features, has raised $54 million in a new funding round.

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...